Confirmed lower risk of hypoglycaemia with insulin glargine versus NPH insulin:: a meta-analysis of 2304 patients with Type 2 diabetes.

被引：0
|
作者：
Rosenstock, J
Benedetti, MM
Häring, HU
Lin, Z
Salzman, A
机构：
[1] Med City Dallas, Dallas Diabet & Endocrine Ctr, Dallas, TX USA
[2] Univ Perugia, Dept Med Interna & Sci Endocrine & Metabol, I-06100 Perugia, Italy
[3] Med Universitatsklin, Tubingen, Germany
[4] Aventis Pharma, Bridgewater, NJ USA
来源：
DIABETOLOGIA | 2003年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
879
引用
收藏
页码：A304 / A304
页数：1
相关论文
共 50 条
  • [21] Pharmacoeconomic analysis of insulin glargine compared with NPH insulin in patients with type 2 diabetes in Spain
    Terres, CR
    Rodríguez, J
    Bolinder, B
    De Pablos, P
    [J]. DIABETES, 2004, 53 : A291 - A291
  • [22] Glycaemic control and hypoglycaemia in Asian Type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
    Pan, CY
    Bianchi-Biscay, M
    Chung, KD
    Kim, KW
    [J]. DIABETOLOGIA, 2004, 47 : A271 - A271
  • [23] Insulin degludec has a lower risk of hypoglycaemia than insulin glargine in patients diagnosed with Type 2 diabetes for >10 years: meta-analysis of five randomised trials
    Vora, J.
    Rodbard, H. W.
    Mersebach, H.
    Kapur, R.
    Harris, S. B.
    [J]. DIABETIC MEDICINE, 2014, 31 : 62 - 62
  • [24] Lower within-subject variability of insulin detemir compared to NPH insulin and insulin glargine in subjects with Type 1 diabetes.
    Heise, T
    Nosek, L
    Draeger, E
    Ronn, BB
    Kapitza, C
    Heinemann, L
    [J]. DIABETOLOGIA, 2003, 46 : A6 - A7
  • [25] A lower rate of nocturnal hypoglycaemia in elderly patients with insulin degludec vs insulin glargine: a meta-analysis
    Atkin, S.
    Sorli, C.
    Warren, M.
    Mersebach, H.
    Johansen, T.
    Oyer, D.
    [J]. DIABETIC MEDICINE, 2013, 30 : 72 - 72
  • [26] Insulin Glargine and Cancer Risk in Patients with Diabetes: A Meta-Analysis
    Tang, Xulei
    Yang, Lin
    He, Zhiyu
    Liu, Jingfang
    [J]. PLOS ONE, 2012, 7 (12):
  • [27] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    [J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
  • [28] Long-acting insulin analogues versus NPH human insulin in type 2 diabetes - A meta-analysis
    Monami, Matteo
    Marchionni, Niccolo
    Mannucci, Edoardo
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (02) : 184 - 189
  • [29] THE EFFECT OF GLARGINE AND NPH INSULIN IN PATIENTS WITH DIABETES MELLITUS TYPE 2
    Nechevska, L.
    Nechevski, M.
    Nechevska, E.
    Boskovski, B.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [30] The association between therapy with insulin glargine versus nph and the risk of myocardial infarction in patients with type 2 diabetes
    Kosiborod, Mikhail
    Zhang, Quanwu
    Foody, JoAnne
    [J]. CIRCULATION, 2007, 116 (16) : 849 - 850
12345